Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

31.80
Delayed Data
As of May 22
 +1.32 / +4.33%
Today’s Change
5.53
Today|||52-Week Range
36.14
+138.02%
Year-to-Date
Blackberry, Exact Sciences, Splunk, Freeport-McMoRan: 'Mad Money' Lightning Round
May 22 / TheStreet.com - Paid Partner Content
Meridian Growth Fund 1Q 2017 Commentary
May 18 / GuruFocus News - Paid Partner Content
Meridian Funds Comments on Exact Sciences Corp
May 18 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close30.48
Today’s open30.71
Day’s range30.17 - 31.83
Volume1,740,643
Average volume (3 months)3,014,341
Market cap$3.4B
Dividend yield--
Data as of 05/22/2017

Growth & Valuation

Earnings growth (last year)+4.68%
Earnings growth (this year)+17.30%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+151.99%
P/E ratioNM
Price/Sales13.76
Price/Book10.02

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-3.50-4.24%
ADAPAdaptimmune Therapeu...+0.02+0.37%
NKTRNektar Therapeutics+0.33+1.74%
XONIntrexon Corp-1.01-4.30%
Data as of 05/22/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$99.4M
Annual profit (last year)-$167.2M
Net profit margin-168.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts